Overview

Effects and Underlying Mechanism of Lipid Lowering Intervention on Vascular Protection in Hypertensive Patients

Status:
Unknown status
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
The purpose of EMINENT study is to evaluate the efficacy of Xuezhikang or atorvastatin in hypertensive patients at low/moderate cardiovascular risk.
Phase:
Phase 4
Details
Lead Sponsor:
Chinese Academy of Medical Sciences, Fuwai Hospital
Collaborators:
Beijing Hospital of Traditional Chinese Medicine
Peking Union Medical College Hospital
Peking University First Hospital
Treatments:
Atorvastatin
Atorvastatin Calcium